Baxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow BAX
Baxter International Inc. (BAX) Revenue
Baxter International Inc.'s revenue for fiscal 2025 was $11.2B, up 5.72% from $10.6B in fiscal 2024. Over the twelve months to 30 June 2026 it was $11.5B. Over the past ten years it has ranged from $10.0B (fiscal 2015) to $12.1B (fiscal 2021); the current reading is higher than 73% of that period. Revenue has risen for 3 consecutive fiscal years. Baxter International Inc. ranks 3rd of 50 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $11.2B | 5.72% |
| FY2024 | $10.6B | 2.66% |
| FY2023 | $10.4B | 3.01% |
| FY2022 | $10.1B | (17.20%) |
| FY2021 | $12.1B | 4.05% |
| FY2020 | $11.7B | 2.74% |
| FY2019 | $11.4B | 2.37% |
| FY2018 | $11.1B | 4.87% |
| FY2017 | $10.6B | 4.14% |
| FY2016 | $10.2B | 1.96% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $3.0B | 9.59% |
| Mar 2026 | $2.7B | (9.18%) |
| Dec 2025 | $3.0B | 4.90% |
| Sep 2025 | $2.8B | 0.89% |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| BAX Baxter International Inc. | $11.5B |
| SOLV Solventum Corporation compare | $8.3B |
| AVTR Avantor, Inc. compare | $6.6B |
| BLCO Bausch + Lomb Corporation compare | $5.3B |
| COO The Cooper Companies, Inc. compare | $4.2B |
| ALGN Align Technology, Inc. compare | $4.1B |
| ATR AptarGroup, Inc. compare | $3.9B |
| WST West Pharmaceutical Services, Inc. compare | $3.3B |
| RGEN Repligen Corporation compare | $785.1M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on BAX
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement